Entellus Medical, Inc. Common Stock
ENTL
ENTL was delisted on the 27th of February, 2018.
83 hedge funds and large institutions have $441M invested in Entellus Medical, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 19 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 14
63% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 19
17% more capital invested
Capital invested by funds: $377M → $441M (+$64.5M)
15% more funds holding
Funds holding: 72 → 83 (+11)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
+$26.2M |
| 2 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$7.68M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$7.25M |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
+$6.68M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$4.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$15.8M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.3M |
| 3 |
Millennium Management
New York
|
-$14.5M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$10.4M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$8.34M |
ENTL Hedge Fund Activity: Q4 2017 in Review
83 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q4 2017, worth a combined $441M — up 17% from $377M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new ENTL positions and 19 closed out — a net gain of 12 holders — while 24 added to existing stakes and 14 trimmed.
The largest buyer was Sand Grove Capital Management, opening a new position worth an estimated $26.2M. The largest seller was Frontier Capital Management, exiting entirely with an estimated $15.8M sold.
- 83 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q4 2017, up from 72 in Q3 2017.
- Funds reported $441M of Entellus Medical, Inc. Common Stock stock for Q4 2017, up 17% quarter-over-quarter.
- 31 funds opened new Entellus Medical, Inc. Common Stock positions in Q4 2017 and 19 closed out, a net change of +12 holders.
- The largest Entellus Medical, Inc. Common Stock buyer in Q4 2017 was Sand Grove Capital Management, an estimated $26.2M added.
- The largest Entellus Medical, Inc. Common Stock seller in Q4 2017 was Frontier Capital Management, an estimated $15.8M sold.
Based on aggregated 13F filings for Q4 2017.